Tune in as Isabel and Jade analyse the standout moments from EMJ GOLD’s guests this season, uncovering the challenges and opportunities shaping today’s pharmaceutical industry.

From self-advocacy at work and the future of personalised medicine to disease awareness, market access and making your marketing efforts stand out – they explore the season’s core themes, all backed by the latest industry data.

Watch our featured guest’s full episodes:

• GSK’s Dheepa Chari on the evolving sphere of scientific communication
• Yacin Marzouki on disrupting the traditional omnichannel model
• BMS’ Anita Gandhi on a decade of change in hematology
• Pfizer’s Richard Maughan on the future of access in the UK
• GSK’s Matt Mortimer-Ryan on behaviour-led pharma marketing
• Chiesi’s Shish Patel on COPD, the climate and improving care
• AbbVie’s Dr Daejin Abidoye on community and compassion in cancer care
• Bayer’s Dr Joana Reis on the promise of AI in breast cancer

How can industry close the screening gap in breast cancer? Find out in this episode, where Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in imaging today.

Together, Jade and Joana discuss her initial interest in a career in radiology, the pivotal role of professional societies in accelerating innovation, how AI is shaping the future of the field and much more.

A little more on EMJ GOLD’s guest…

Dr Joana Reis was appointed Medical Affairs Breast Lead for radiology at Bayer in January of 2025. Before this, she was the Medical Affairs Lead for digital radiology at the company, where she developed strategies focusing on AI applications in imaging. Before joining Bayer, Joana worked as a Senior Consultant Breast Radiologist at Akershus University Hospital in Oslo, Norway.

Tune in as Dr Daejin Adiboye, Vice President, Therapeutic Area Head, Solid Tumor Oncology, AbbVie, explores both the evolution of cancer care and his leadership style over the last two decades.

Together, Daejin and Jade discuss the lessons from his time in the clinic that shaped who he is today, the move to precision medicine in oncology, his work with the Cancer Support Community in San Francisco and much more.

A little more on EMJ GOLD’s guest…

Dr Daejin Abidoye serves as Vice President, Therapeutic Area Head for Solid Tumor Oncology at AbbVie. In this role, he is responsible for the clinical development of all assets in late oncology clinical development. His career includes over 20 years of experience in oncology, cancer research and drug development. Prior to joining AbbVie, Daejin was the Therapeutic Area Lead for Oncology Development and Clinical Research at Gilead Sciences. He has also held various roles at Seattle Genetics and Roche-Genentech. Dr. Abidoye is a board-certified oncologist with a career in clinical practice at Scripps Health in Southern California.